Should Cannabinoids Be Recommended to Patients With Neuropathic Pain?
Two expert physicians with opposing viewpoints debate the risks and benefits of using cannabinoids for treating neuropathic and chronic pain.
Two expert physicians with opposing viewpoints debate the risks and benefits of using cannabinoids for treating neuropathic and chronic pain.
Tori Rodriguez, MA, LPC, discusses chronic pain among patients with Parkinson disease and the breakdown of disease subtypes, classification, and pathophysiology.
Access to primary care is limited for patients taking opioids for chronic pain, particularly for patients with histories suggestive of aberrant use of opioids.
A digital health app designed to track and report on patient perceived pain relief and general well-being associated with spinal cord stimulation will be made available soon.
Recently updated diagnostic criteria for fibromyalgia that reduce the underdiagnosis in men had not been implemented during these studies.
Dr Nicola Davies discusses the potential of deep brain stimulation for the treatment of chronic pain.
People with chronic pain and multiple sclerosis often describe their pain as a combination of nociceptive, nociplastic, and/or neuropathic pain characteristics.
In patients with dementia, pain is a correlate or prodromal symptom rather than a direct cause of dementia.
Patients with neuromyelitis optica spectrum disorder who experience relapses use more pain medication than non-relapsing patients.
Changes in connectivity between the dorsal anterior cingulate cortex and regions of the brain involved in pain processing and motor control may predict the development of chronic pain months after a motor vehicle crash.